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Preface
The Nordic Council of Ministers is an intergovernmental collaborative body for
the five countries, Denmark, Finland, Iceland, Norway and Sweden. One of the
committees, the Nordic Senior Executive Committee for Occupational
Environmental Matters, initiated a project in order to produce criteria documents
to be used by the regulatory authorities in the Nordic countries as a scientific basis
for the setting of national occupational exposure limits.
The management of the project is given to an expert group. At present the
Nordic Expert Group for Criteria Documentation of Health Risks from Chemicals
consists of the following members:
Gunnar Johanson (chairman) National Institute for Working Life, Sweden
Vidir Kristjansson Administration of Occupational Safety and Health,
Iceland
Kai Savolainen Finnish Institute of Occupational Health, Finland
Vidar Skaug National Institute of Occupational Health, Norway
Leif Simonsen National Institute of Occupational Health, Denmark
For each document an author is appointed by the Expert Group and the national
member acts as a referent. The author searches for literature in different data bases
such as Toxline, Medline, Cancerlit and Nioshtic. Information from other sources
such as WHO, NIOSH and the Dutch Expert Committee on Occupational
Standards is also used as are handbooks such as Patty's Industrial Hygiene and
Toxicology. Evaluation is made of all relevant scientific original literature found.
In exceptional cases information from documents difficult to access is used.
However, only literature judged as reliable and relevant for the discussion is
referred to in this document.
The document aims at establishing dose-response / dose-effect relationships and
defining a critical effect based only on the scientific literature. The task is not to
give a proposal for a numerical occupational exposure limit value.
The evaluation of the literature and the drafting of this document on toluene
was made by Dr Grete Østergaard, Danish Veterinary and Food Administration,
Institute of Food Safety and Toxicology. The draft document was discussed
within the Expert Group and the final version was accepted by the Nordic Expert
Group August 18, 2000, as its document.
Editorial work was performed by the Group's Scientific Secretary, Jill Järnberg,
and technical editing by Karin Sundström both at the National Institute for
Working Life in Sweden.
We acknowledge the Nordic council for its financial support of this project.
Jill Järnberg Gunnar Johanson
Scientific Secretary Chairman
Abbreviations
FSH follicle stimulating hormone
GLP good laboratory practice
NOAEL no observed adverse effect level
LC50 lethal concentration for 50% of the exposed animals
LD50 lethal dose for 50% of the exposed animals
LH luteinising hormone
LOAEL lowest observed adverse effect level
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11. Introduction
Toluene is a component of crude oil and is produced by different petroleum
distillation conversion processes. Isolated toluene is used in industry as a chemical
intermediate and as a solvent. Toluene is a high production volume substance.
Workers in the chemical industry and paint industry, and workers using products
containing toluene (e.g. painters) may be occupationally exposed.
2. Substance identification
CAS No. 108-88-3
EINECS No. 203-625-9
IUPAC name Toluene
Synonyms methyl benzene, phenyl methane, toluol
methyl benzol, methacide
Molecular formula C7H8
Molecular weight 92.13 g/mol
Structural formula
3. Physical and chemical properties
Boiling point at 101.3 kPa 110.6oC
Melting point at 101.3 kPa -95oC
Vapour pressure at 25oC 3.73 kPa
Density at 20oC 0.876 g/ml
Vapour density (air=1) 3.20
Saturation concentration 142 000 mg/m3
(in air at 25oC)
Explosive limits (vol% in air) 1.17 - 7.10
Log partition coefficient 2.69
(octanol/water)
Flame point 4.4oC
CH3
2Odour threshold 1.5 - 3.2 mg/m3 (48)
17.5 -262.5 mg/m3 (135)
11 ± 6 mg/m3 (3)
Conversion factors at 25oC 1 mg/m3 = 0.267 ppm
1 ppm = 3.75 mg/m3
Toluene is a colourless, flammable liquid with unpleasant aromatic odour. Water
solubility at 20oC is approximately 6.5 mmol/l. Toluene is soluble in acetone and
carbon disulphide, and miscible with most ethers, ketones, alcohols, esters, and
aliphatic and aromatic hydrocarbons. Toluene forms azeotropic mixtures with
many of the solvents mentioned above. Toluene is used as solvent in a number of
products such as bitumen, tar, paints, lacquers, greases, and natural and synthetic
resins.
4. Occurrence, production and use
Toluene occurs naturally and natural sources are volcanoes and forest fires.
Toluene is naturally present in small amounts in crude oil. In the petroleum
refinery process, this toluene will be present in low concentrations in straight-run
gasoline products. By different petroleum conversion processes (catalytic
reforming, powerforming, catalytic cracking, hydrocracking, steam cracking etc.)
the yield of useful products from crude oil is upgraded, producing olefinic and
aromatic rich streams containing benzene, toluene and xylenes in varying
concentrations. Most of the refinery / cracker streams containing toluene are used
as a base or blending feedstock to produce motor gasoline. In order to produce the
commercial product toluene, a fraction of the toluene-rich streams is segregated,
distilled and purified.
As an intermediate in the chemical industry, toluene is used as a raw material in
the organic synthesis of other chemicals e.g. benzaldehyde, benzene, benzoic acid,
benzyl chloride, phenol, toluene diisocyanate, xylene and other derivatives used as
dye intermediates, resin modifiers and germicides. Toluene is also used in the
synthesis of explosives (TNT), vinyl toluene, cresols and flavouring agents.
Toluene is used as a solvent for paints, lacquers, gums, resins, and in the
extraction of various substances from plants. Approximately 20% of isolated
toluene sold as solvent is used in paints, inks, thinners, coatings, adhesives,
degreasers and other formulated products requiring a solvent carrier.
Because of the vast amount of products in which toluene is used, either as
intermediate or as solvent, toluene is found in most industrial categories. The
main exposure to toluene occurs by inhalation of vapours and liquid aerosols and
via dermal exposure to liquids. Further, toluene is used as an additive in cosmetic
products.
A large part of the annually produced toluene is used as a constituent of
gasoline. Toluene increases the octane number.
3In Denmark, the Danish Product Registry (1996) data on toluene registered
approximately 2 700 products with an annual use of 19 000 tonnes toluene. The
Danish product types covering more than 50 functions / uses include solvents,
adhesives and binding agents, paints, lacquers and varnishes, and intermediates.
The industry groups were chemical industry, manufacture of metal articles, textile
and clothing industry, reprographic industry, wood and furniture industry, and
construction industry distributed in 28 trades.
In Norway, 880 toluene-containing products were registered in 1996, with a
total toluene tonnage of 370 000. From 1992 to 1998 the number of products
containing toluene has risen from 517 to (estimated) 875. The estimated tonnage
for 1998 was 410 000 (Information from the Norwegian Product Register 1999).
5. Occupational exposure data
Occupational exposure may occur during:
Production of toluene, including storage and handling (i.e. transfer from one
container to another), sampling and analysis of quality control samples, cleaning,
repair and maintenance of the equipment.
Production, storage and handling of toluene-containing products (semi-
products as well as products for sale), sampling and analysis of quality control
samples, cleaning, repair and maintenance of the equipment.
Use of toluene-containing products (occupational exposure and consumer
exposure) sampling and analysis of quality control samples, cleaning, repair and
maintenance of the equipment.
Commonly, maintenance workers may be exposed to high exposure concentra-
tions, but of short duration. Workers performing sampling for product control
usually experience high exposure concentrations of very short duration, but
exposures may be frequent.
Within production of toluene in the chemical industry, a reasonable worst case
short term exposure level is 100 mg/m3, while the typical full shift exposure level
is low, 3 mg/m3. For production of toluene-containing products, a reasonable
worst case short-term exposure level is 200 mg/m3, while the typical full shift
exposure level is low, 4 mg/m3. Occupational use of toluene-containing products
can lead to high exposure levels. For use of toluene-containing adhesives and inks
the typical full shift exposure level is 75 mg/m3. These values derive from the EU
risk assessment of toluene (31).
6. Measurements and analysis of workplace exposure
The most widely used analytical technique for quantifying toluene in environ-
mental samples is gas chromatography. Air samples may be collected and
concentrated on adsorbent or in canisters for subsequent analysis. Sampling
4techniques include collection in sample loops, on adsorbents, in canisters, and by
cryogenic trapping. Detection limits depend on the amount of air sampled (158).
7. Toxicokinetics
7.1 Uptake
7.1.1 Skin
Liquid toluene can be absorbed through the skin. In five volunteers exposed to
toluene by immersing a hand up to the wrist in liquid toluene for 30 minutes,
maximum concentrations of toluene in blood (0.17 mg/l) were found 30 minutes
after start of the exposure. The maximum blood toluene concentration was
maintained for 10-15 minutes after exposure had ended and was a quarter of that
achieved in a two-hour inhalation exposure to 100 ppm (375 mg/m3) toluene
vapour (139).
Ten male volunteers were exposed in a dynamic exposure chamber, with
respiratory protection, to toluene vapour (2250 mg/m3 (600 ppm)). To keep the
skin practically unprotected, the subjects wore only thin pyjamas and socks. The
exposure was therefore to the skin of the whole body. Steady state occurred after
30 minutes with a toluene concentration of 1.08 µmol/l (100 µg/l) in venous
blood. The total duration of exposure was 3.5 h. Based on average values for lung
retention and lung excretion of toluene it was estimated that the percutaneous
uptake of toluene vapour amounted to approximately 1% of the respiratory uptake
at the identical air concentration (130). A similar relation between lung and per-
cutaneous uptake of toluene vapour is given elsewhere (117).
The capability of toluene to penetrate the skin was investigated in isolated rat
skin. At steady state a penetration of 8.5 nmol/cm2/min (0.78 µg/cm2/min) was
determined (157).
In conclusion, dermal uptake after skin exposure to liquid toluene occurs to a
limited degree. Dermal exposure to toluene vapours is not likely to be an impor-
tant route.
7.1.2 Lungs
The major uptake of toluene vapour is through the respiratory system. A number
of investigations in humans (21, 22, 110, 178) have shown that at rest a three-hour
exposure to toluene vapour will result in an uptake amounting to approximately
50% of the inhaled toluene across the exposure levels tested (300-400 mg/m3,
approximately 100 ppm).
The concentration of toluene in alveolar air and in arterial and venous blood
rises quickly during the first 10-15 minutes of exposure (21, 179). After only 10
seconds of exposure toluene can be detected in blood from brachial arteries (179).
Data from experimental exposure of voluntary study subjects show that
physical work results in increased toluene uptake (21, 163). Using a 50 W work
load, exposure to 300 mg/m3 (80 ppm) toluene for 2 hours did not result in steady
5state of the blood concentration of toluene in 12 study subjects. The toluene
uptake was 2.4 times higher than the uptake at rest. During the work, lung ventila-
tion was increased 2.8 times. Concentrations of toluene in alveolar air and blood
increased with increasing work loads (0-150 W in periods of 30 minutes) (21).
However, at higher workloads the proportion of toluene taken up decreased (only
29% at 150 W compared with 52% at rest), indicating that the uptake is limited by
the rate of removal of toluene from the lungs via blood (89). The amount of
toluene absorbed increased with greater amounts of body fat (23).
In nine male volunteers exposed to 200 mg/m3 (53 ppm) toluene for 2 hours
during a workload of 50 W the total uptake of toluene was 50% of that inhaled
(91).
7.1.3 Gastro-intestinal tract
Case reports of accidents and attempted suicides, and clinical trials involving
toluene administration to leukaemia patients (14) show that toluene is absorbed
via the alimentary system in humans.
In rats, uptake of toluene via the alimentary system is slower than the respira-
tory uptake. Toluene concentration in blood reached maximum values two hours
after an oral dose (126). About 76% was recovered as hippuric acid in the urine
(76), and approximately 18% was excreted as toluene vapour through the respira-
tory system (145), suggesting that absorption is nearly 100%.
7.2. Distribution
The blood/air partition coefficient for toluene is 11.2-15.6 at 37oC (87, 137, 138,
141, 159).
The distribution of toluene is among other factors dependent on the tissue
partitioning and the metabolism. In rabbits, the following tissue/blood partition
coefficients have been found: brain, heart, liver, and intestine: 2.3, muscle tissue:
1.6, adipose tissue: 74.3, bone, connective tissue, and lung tissue: 1.9 (140). In
rats, brain/blood ratios of 1.2 (74) and 1.7 (175) have been determined. In
humans, the adipose tissue/blood partition coefficient of toluene is determined to
be 81-83 (140, 141).
Whole body autoradiography of mice after acute inhalation of 14C toluene (9)
showed high radioactivity in adipose tissue, bone marrow, spinal nerves, spinal
cord, and in the white parts of the brain, and somewhat lower activities in blood,
liver, and kidneys. One hour after exposure nerve tissue showed no radioactivity.
In adipose tissue nearly all radioactivity had disappeared after four hours, and
only traces of non-volatile radioactivity could be found in the liver. After 24 hours
all radioactivity had disappeared from the body.
Toluene passes the placental barrier. Two hours following exposure of rats via
inhalation to 1375 or 2700 mg/m3 (367 or 720 ppm) for 24 hours, foetal blood had
a toluene concentration of 74% of that found in the dam’s blood. The amniotic
liquid contained a toluene concentration of 5% of that in the dam’s blood. Four
6and six hours after exposure, similar relative toluene concentrations were found
(Ungvary 1984, quoted from (62)).
Groups of four mice (11, 14 or 17 days pregnant) were killed 0, 30, 60 and 240
minutes after having inhaled 7500 mg/m3 (2000 ppm) 14C-toluene for ten minutes.
Radioactivity as volatile and non-volatile was measured in lung, liver, kidney,
brain, cerebellum, fat, plasma, amniotic fluid, placenta, and foetus. It was shown
that toluene immediately after inhalation was taken up in the foetal tissue at a
concentration of about 10% of that found in the maternal lungs. It was suggested
by the authors that this could be due to the fact that the foetus does not contain
any lipid-rich tissue. At four hours after exposure the toluene radioactivity was
decreased to 2% of the original value (44).
Toluene has been found in human breast milk. In 12 pooled samples from four
urban areas in the United States, toluene was identified qualitatively in at least 7
samples (Pellizzari et al., 1982, quoted from (67)).
7.3 Biotransformation
Biotransformation of toluene occurs mainly by oxidation. The endoplasmatic
reticulum of liver parenchymal cells is the principal site of oxidation that involves
the cytochrome P-450 system. Analysis of blood and urine samples from workers
and voluntary study subjects exposed to toluene via inhalation in concentrations
ranging from 100 to 600 ppm (375-2250 mg/m3) indicate that approximately 99%
of the biotransformed toluene is oxidised via benzyl alcohol and benzaldehyde to
benzoic acid. The remaining 1% is oxidised in the aromatic ring, forming ortho-,
meta- and para-cresol (172, 173).
Water solubility of the biooxidation products is achieved through linkage with
suitable substances (phase 2 reaction). Benzoic acid is linked to either glycine or
glucuronic acid forming either hippuric acid or benzoyl glucuronide. Cresols and
benzyl alcohol are linked to glucuronic acid or sulphate (62). At heavy toluene
exposures there may not be enough glycine available for conjugation with the
toluene metabolite benzoic acid to form hippuric acid. Benzoic acid may then be
conjugated with glucuronic acid, and excreted as benzoyl glucuronide.
7.4 Excretion
7.4.1 Lungs
Data from experimental inhalation exposure of voluntary subjects show that the
toluene concentration in expired air decreases rapidly during the first 10 to 20
minutes after cessation of exposure to toluene via inhalation (21, 33, 162). Two to
four hours later, very low toluene concentrations are found in expired air (21). Of
the toluene absorbed, 15-20% is exhaled during the first few hours after exposure
has stopped (110). The cumulative excretion of toluene via the lungs amounts to
4-8% and 7-14% after 2 and 20 hours, respectively (21). The cumulative excretion
(in per cent) of toluene via the lungs appears to increase with increasing amounts
of toluene taken up (21).
77.4.2 Kidney
The majority (80-90%) of absorbed toluene is biotransformed and excreted from
the body via the kidneys. At an exposure level of 750 mg/m3 (200 ppm), the
excretion is mainly as hippuric acid. About 1% of the biotransformed toluene is
excreted as glucuronides or sulphates of o-, m-, or p-cresol (62).
p-Toluylmercapturic acid and S-benzylmercapturic acid have been identified as
urinary metabolites of toluene in human studies (158).
A very small proportion, approximately 0.06% of the toluene absorbed via
inhalation, is excreted unchanged in the urine in man (168).
7.4.3 Gastro-intestinal tract
In rats, a small proportion, less than 2%, of the absorbed toluene is excreted via
the bile to the intestine. The substances excreted are reabsorbed in the intestine.
Thus, very small amounts are excreted in faeces (2).
7.5 Biological half-lives
In humans, two hours' inhalation of 375 mg/m3 (100 ppm) and determination of
the time course of toluene in blood and expired air after exposure gave a three-
phasic decay curve. Biological half-lives of 2 minutes, approximately 30 minutes,
and approximately 3.5 hours, respectively, were calculated (140). Half-lives of 22
minutes and 175 minutes for the two last phases have also been determined (136).
In a study of workplace accidents with coma as a result of exposure to high
toluene concentrations, a fourth phase with a 20-hour half-life was found. This
phase is taken to represent toluene elimination from adipose tissue (16). Nise et al.
(108) have found elimination curves for toluene in venous blood to contain at least
three exponential components with median half-lives of nine minutes, 2 hours and
90 hours in rotogravure printers exposed to a time weighted median concentration
of toluene of 75 mg/m3 (range 8-416 mg/m3) during a 5-day working week. The
third component reflected the decline of toluene in adipose tissue, which had a
median half-life of 79 hours as measured in subcutaneous adipose tissue.
According to the authors the slower elimination from blood compared to fat could
be due either to an overestimate of the half time in blood or to a decay of the
biotransformation of toluene towards the end of the study period. The median
venous blood toluene concentration was found to be 2.3 µmol/l at the end of a
week’s last shift. After 72 hours the blood toluene concentration had fallen to
0.16 µmol/l. In another part of the same study toluene concentrations were
determined in venous blood and subcutaneous adipose tissue at 0, 63, and 135
hours. In venous blood an initial median toluene concentration of 1 µmol/l was
found. After 135 hours the toluene concentration had decreased to 0.06 µmol/l. In
subcutaneous adipose tissue the corresponding median toluene concentrations
were 4 mg/kg fat and 1 mg/kg fat, respectively. Carlsson & Ljungquist (23)
reported that the half-life of toluene from subcutaneous adipose tissue increased
with increasing amounts of body fat. The range of values for the half-life was
from 0.5 to 2.7 days. The variation in half-lives may be a matter of sample
8collection strategies, and related to variations in exposure levels and durations. An
important point is that the slow elimination of toluene from adipose tissue may
result in accumulation of the chemical in adipose tissue in humans after repeated
daily exposure. In rats, the rate of elimination from fat seems to be much higher
than in humans, as only a few percent of the toluene concentration found in
perirenal fat immediately after end of exposure to 100 ppm was recovered 12
hours later (175).
7.6 Metabolic (toxicokinetic) interactions
In the previous version of the NEG criteria document on toluene (66) inhibition of
toluene metabolism by ethanol is described. Toluene excretion was independent of
previous toluene exposure, age, body weight, and previous alcohol consumption.
Smokers showed a tendency to faster excretion of blood toluene via the lungs.
Volunteers were exposed to toluene via inhalation for 4 h (300 mg/m3) with or
without prior ingestion of paracetamol (14 mg/kg), or with or without prior
ingestion of acetylsalicylic acid (14 mg/kg) (90). Paracetamol, but not acetyl-
salicylic acid, reduced the apparent blood clearance by 13%, while urinary
excretion of hippuric acid was not affected.
In a recent review (89) investigations in humans of toxicokinetic interactions
between toluene and other industrial solvents are described. The solvents may
decrease each other’s biotransformation rates resulting in increased toluene levels
in blood and delayed excretion of urinary metabolites. This has been shown for
xylene and benzene co-exposure with toluene, while no effect was seen after
exposure to methyl ethyl ketone and toluene.
8. Methods of biological monitoring
8.1 Biological markers
Measurements of toluene in blood, urine and exhaled air provide reliable markers
of exposure to toluene. Measurement of toluene metabolites is also utilised for
monitoring toluene exposure in humans. Hippuric acid is formed in the body by
the metabolism of toluene. High performance liquid chromatography (HPLC)
with ultraviolet detection is usually used for detection of hippuric acid in urine.
Other metabolites such as o-cresol, benzylmercapturic acid, or S-p-toluyl-
mercapturic acid may also be measured (158).
A good correlation was found between toluene exposure (air concentration
multiplied by time) and concentration of hippuric acid in post exposure urine.
However, a background level of hippuric acid is present in human urine, as a
product of endogenous metabolism, and of metabolism of substances present in
food. In the Western part of the world, at exposure levels below 100 ppm
(375 mg/m3) hippuric acid in post exposure urine cannot be used to separate an
exposed person from an unexposed one because the difference between the back-
9ground level and the toluene-generated level is too small (84). However, hippuric
acid background levels in urine vary geographically. In some countries (e.g.
Taiwan and Croatia) a low urinary hippuric acid background level is found. Thus,
in these parts of the world it is possible to use this metabolite as a biological
marker for toluene exposure even at exposure levels lower than 100 ppm (25, 158,
164, 166).
9. Mechanisms of toxicity
The exact toxicological mechanism of toluene is not known. Several mechanisms
have been proposed. Toluene alters the lipid structures of cell membranes and
thereby changes intercellular communication and the movement of ions and/or
biomolecules between cells and the interstitial fluid. Toluene interacts with the
hydrophobic portions of cell proteins to alter either membrane-bound enzyme
activity or receptor-site specificity. The metabolic path in which toluene is
metabolised into o-cresol and p-cresol includes an arene oxide intermediate,
which binds to cell proteins and RNA, thereby modifying their function (158).
10. Effects in animals and in vitro studies
10.1 Irritation and sensitisation
10.1.1 Skin irritation
The skin irritancy of toluene in rabbits was tested by four different methods,
including the OECD guideline 404 method (46). The same scoring system was
used to measure results from all four methods. Toluene was found slightly
irritating by the OECD guideline method, and moderately irritating by the other
methods.
10.1.2 Eye irritation
In a rabbit eye irritation study toluene was judged to be a moderate to severe
irritant with corneal involvement or irritation that persisted for more than 24 hours
but recovered within 21 days after treatment (149).
Toluene was also found to be an eye irritant in another study, which appears to
have been performed by a method resembling the OECD guideline method (47).
10.1.3 Sensitisation
No published data have been found.
10.1.4 Respiratory irritation
In mice, RD-501 values of 12 590 mg/m3 (98), 12 650 mg/m3 (3373 ppm) (32),
and 19 875 mg/m3 (5300 ppm) (106) have been determined, suggesting that
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 Respiratory rate depression
10
Table 1.  Acute lethality data for toluene compiled from various sources
Species Exposure route LC50 (inhalation)
LD50 (oral, dermal, intra-peritoneal application)
Reference
Rat Inhalation 1 h >100 000 mg/m3 8
Rat Inhalation 6 h 22 000 - 23 500 mg/m3 11
Rat Inhalation 6.5 h 45 800 mg/m3 19
Mouse Inhalation 6 h 24 000 - 27 900 mg/m3 11
Mouse Inhalation 6 h 26 000 mg/m3 12
Mouse Inhalation 7 h 19 900 mg/m3 154
Rat Oral 7.5 g/kg 146
Rat Oral 5.9 g/kg 161
Rat Oral 5.5 g/kg 73
Rat Oral 5.6 g/kg 171
Rat Oral 7.0 g/kg 174
Rabbit Dermal 12.4 g/kg 146
Rat Intraperitoneal 1.6 g/kg 34, 61, 88
Mouse Intraperitoneal 2.15 g/kg 77
LC50 = lethal concentration for 50% of the exposed animals
LD50 = lethal dose for 50% of the exposed animals
toluene can cause irritation to the respiratory tract at these high concentrations.
The irritative effect of lower toluene concentrations has not been examined.
10.2 Effects of single exposure
10.2.1 Inhalation
Toluene has low acute toxicity via inhalation and the oral route (Table 1). In rats,
inhalatory LC50 values in the range of 20 000-50 000 mg/m3/6h, and oral LD50
values of 5.5-7.5 g/kg have been reported. A dermal LD50 of 12.4 g/kg has been
determined in the rabbit. Via the intraperitoneal route LD50s of approximately
2 g/kg for rats and mice have been found.
10.3 Effects of short-term exposure
10.3.1 Liver
In mice, rats, and rabbits exposed via inhalation to 2000 mg/m3 or 3000 mg/m3
toluene, either for 24 hours or 8 hours per day for 1-3 weeks, the cytochrome
P450 and cytochrome b5 concentrations were increased (161).
10.4 Effects of long-term exposure and carcinogenicity
10.4.1 General toxicity, inhalation
Rats, 15 weeks
Groups of ten male and ten female F344/N rats were exposed via inhalation to 0,
100, 625, 1250, 2500, or 3000 ppm toluene 6.5 h/day for 5 days/week for 15
weeks (56). Effects included dyspnea, ataxia, body weight reduction, increased
relative liver, brain, heart, lung, kidney, and testes weight. The leukocyte count
11
was decreased for female rats at 1250 ppm or higher. No compound-related
effects were seen on sperm or oestrous cycle. Among the high-dose males
8 deaths occurred during the second week of exposure. Overall, a no observed
adverse effect level (NOAEL) of 625 ppm toluene (2350 mg/m3) for 15 weeks’
inhalation exposure of rats can be derived from this study. At 1250 ppm and
above, a decrease in leukocyte count in females was found. Also, at and above
1250 ppm weight changes in a number of organs were detected.
Rats, 2-year exposure
Groups of 120 male and 120 female Fisher F344 rats were exposed via inhalation
to toluene 6.5 h per day/5 days/week for up to 24 months in concentrations of 0,
112, 375 or 1125 mg/m3 (0, 30, 100, 300 ppm) (45). No substance related adverse
changes were found with respect to clinical signs, body weight, haematology,
blood chemistry or urinalysis. No gross pathological or histopathological changes
related to toluene exposure were seen. The NOAEL was 300 ppm.
Rats, 15-month and 2-year exposure
Groups of 60 male and 60 female F344N rats were exposed by inhalation to 0,
600, or 1200 ppm toluene 6.5 hours/day 5 days/week for two years in a GLP
(good laboratory practice) study. At 15 months, 10 male and 10 female rats at
each dose level were terminated (56).
Rats, 15-month and 2-year exposure: 15-month exposure. In the nasal cavity, mild
to moderate degeneration of the olfactory and respiratory epithelium was more
obvious in toluene-exposed rats and goblet cell hyperplasia was somewhat
increased whereas other lesions (necrosis, metaplasia) were seen in a few exposed
rats. The incidences and severity of chronic inflammation were greater in exposed
females than in controls. Hyperplasia of the alveolar and bronchiolar epithelium
was found in two males and three females in the 1200 ppm group and in one
control female. In this study, the lowest exposure level (600 ppm) caused toxic
effects in the nasal epithelium (56).
Rats, 15-month and 2-year exposure: 2-year exposure. Mean body weights of rats
exposed to 1200 ppm were 4-8% lower than those of controls. No compound-
related clinical signs were recorded, and no significant differences in survival
were observed between any groups of either sex. In the nose, erosion of the
olfactory epithelium and degeneration of the respiratory epithelium were
significantly increased in exposed rats. Inflammation of the nasal mucosa and
respiratory metaplasia of the olfactory epithelium were observed at significantly
(P < 0.05) increased incidences in exposed female rats. Forestomach ulcers were
marginally increased in exposed male rats. The severity of nephropathy was
increased with exposure concentration in both sexes. The lowest observed adverse
effect level (LOAEL) was 600 ppm for nasal toxicity, forestomach ulcers, and
kidney damage (56).
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Mice, 14-week exposure
Groups of 10 male and 10 female B6C3F1 mice were exposed to 0, 100, 625,
1250, 2500, or 3000 ppm toluene 6.5 hours/day, 5 days/week for 14 weeks.
Effects included deaths at 625 ppm and above, body weight decrease, dyspnea,
increased relative weight of liver, lung, and kidney. Centrilobular hepatocellular
hypertrophy was observed in all male mice at 2500 ppm and 4/6 male mice at
3000 ppm. No effect on sperm count or motility or on oestrous cycle were seen.
Mice, 15-month and 2-year exposure
Groups of 60 male and 60 female B6C3F1 mice were exposed by inhalation to 0,
120, 600, or 1200 ppm toluene 6.5 hours/day, 5 days/week for 2 years in a study
of GLP quality. Ten female mice at each exposure level were terminated after
15 months (56). In female mice exposed for 15 months no toluene-induced effects
were seen on body weight, absolute or relative organ weights of brain, kidney or
liver. Haematological parameters were unaffected by exposure. Minimal
hyperplasia of the bronchial epithelium was seen in females at 1200 ppm.
In the 2-year study, body weights in female mice were slightly lower at
1200 ppm compared with controls. No significant differences in survival were
observed between any groups of either sex.
10.4.2 General toxicity, oral
Groups of 10 male and 10 female F344N rats received 0, 312, 625, 1250, 2500, or
5000 mg toluene/kg body weight in corn oil by gavage for 13 weeks (56). Effects
included death, body weight reduction, prostration, hypoactivity, ataxia, pilo-
erection, lacrimation, and excessive salivation. Liver and heart weights were
increased, while brain weight was reduced in both sexes at 2500 mg/kg. Neuro-
pathological changes in the brain, consisting of neuronal cell necrosis in the
dentate gyrus and Ammons horn of the hippocampus, were seen in male and
female rats that received 2500 or 1250 mg/kg. In addition to the hippocampal
lesions, necrosis and/or mineralisation was present in the granular layer of the
cerebellar cortex. Haemorrhage was present in the mucosa, submucosa, or
muscularis layer of the urinary bladder of males and females of the two highest
dose groups. The dose level 625 mg/kg is considered the NOAEL. At doses of and
above 1250 mg/kg, neurone necrosis in the brain was found, which is clearly an
adverse effect (56).
Groups of 10 male and 10 female B6C3F1 mice received 0, 312, 625, 1250,
2500 or 5000 mg toluene/kg in corn oil by gavage for 13 weeks (56). All mice that
received 5000 mg/kg died during the first week, 4 male and 4 female rats that
received 2500 mg/kg and one female mouse that received 1250 mg/kg died before
termination of the study. Effects included body weight decrease, subconvulsive
jerking, prostration, impaired grasping reflex, bradypnea, hypothermia, hypo-
activity, and ataxia. Liver, brain, testis, and kidney weight were increased with no
accompanying histopathology mentioned. The NOAEL is considered to be
625 mg/kg (56).
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10.4.3 Specific organ toxicity
Liver
In rats exposed via inhalation to 1000 mg/m3, 1500 mg/m3, 3000 mg/m3, 3500
mg/m3 or 6000 mg/m3 toluene 8 hours/day for up to 6 months, reversible dose-
dependent increases in relative weight of the liver, succinate dehydrogenase
activity, and concentration of cytochrome P-450 and b5, and a decrease in
glycogen content were reported (160).
Nervous system
Groups of male rat pups were exposed to 0, 100, or 500 ppm (0, 375, or 1875
mg/m3) toluene for 12 hours/day on postnatal days 1-28. Histological and
volumetric examination of the hippocampus on postnatal day 28 (n=7) revealed a
reduced volume of various subregions in the area dentata at both exposure levels.
However, the difference at 100 ppm may be due to an atypical value in the control
group for this exposure group and is therefore not considered reliable. On day 120
(n=6) no differences were apparent in the volumes of the dentata components
(143, 144).
Groups of six rats were exposed to 0 or 1500 ppm (5625 mg/m3) toluene via
inhalation for 6 h/day, 5 days/week for 6 months. A statistically significant neuron
loss of 16% was found in the regio inferior (CA3 and CA2) of the hippocampus in
exposed rats after an exposure-free period of 4 months (78).
Groups of 36 rats were exposed to 0, 500, or 1500 ppm (0, 1875, or 5625 mg/m3)
toluene via inhalation 6 h/day, 5 days/week for 6 months followed by an exposure-
free period of two months prior to testing and sacrifice. The weight of the hippo-
campus was dose-dependently reduced (statistically significant at 1500 ppm), and
an increase in perikaryal volume and nuclear volume in the neocortex was found at
500 ppm. Noradrenaline, dopamine and 5-hydroxytryptamine levels were signi-
ficantly changed in various brain regions at 500 and 1500 ppm (80).
Groups of 8 male Wistar rats were exposed to 0, 100, 300, or 1000 ppm (0, 375,
1125, 3750 mg/m3) toluene 8 hours/day, 6 days/week for 16 weeks (54). Measure-
ment of the content of various neuronal and glial marker proteins revealed dose-
related changes in some brain regions. The changes were interpreted by the
authors as possible first steps in toluene neurotoxicity. The biological significance
of these changes in marker proteins is not known, and it is considered that they are
not directly adverse effects.
Auditory system toxicity
Auditory impairment of toluene-exposed rats has been demonstrated in a number
of studies as behavioural and electrophysiological changes at exposure concentra-
tions between 900 and 1400 ppm 14h/day, 7 days/week, for 5-14 weeks (123, 124,
127).
The dose-response relationship between toluene and hearing loss in rats was
investigated in a series of experiments in male Fischer rats. Toluene ototoxicity
was manifest only at relatively intense schedules of exposure. The toluene
concentration and the duration of exposure must be above a certain level before
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hearing loss will occur. A LOAEL of 1000 ppm (14h/day, 2 weeks) and a
NOAEL of 700 ppm (14h/day, 16 weeks) was found (125).
There was no control for noise in any of the above-mentioned studies.
A group of 13 male Sprague-Dawley rats inhaled 1400 ppm toluene 16 h/day
for a maximum of 8 days (48). Light microscopy or scanning electron microscopy
examination of the cochlea revealed a progressive severe loss of hair cells. The
auditory brainstem response threshold was increased with an average loss of
auditory sensitivity of about 20-40 dB compared with control rats, and the loss
was greater with increasing number of days of exposure (68)
Further descriptions of the morphological appearance of toluene-induced
cochlear damage have been published (20, 83, 150).
Interaction with toluene on auditory function: Noise.
Groups of 8-12 male Sprague-Dawley rats were exposed to ambient air, to
1000 ppm toluene 16 h/day, 5 days/week, for 2 weeks, to noise (105 dB Sound
Pressure Level (SPL)) 10 h/day, 7 days/week, for 4 weeks, or to toluene followed
by noise (same dose and schedule) (69). The decrease in auditory sensitivity in
rats exposed to toluene followed by noise was greater than the summated effects
of each factor alone, indicating a synergistic rather than additive toxic effect of
toluene and noise on auditory functions.
Synergism of simultaneous exposure to toluene and noise was found in a study,
which also described the different nature of the cochlear damages induced by
noise alone or by toluene alone (83). Noise induces injury to stereocilia, while
toluene induces outer hair cell loss.
Interaction with toluene on auditory function: Ethanol
Rats were exposed to ambient air, to toluene alone (1000 ppm, 21 h/day, 8
weeks), to toluene plus ethanol, or to ethanol alone (112). Auditory function was
reduced in the toluene-exposed groups, but not in the group exposed to ethanol
alone. Ethanol counteracted the effect of toluene on auditory sensitivity.
Interaction with toluene on auditory function: n-Hexane
Groups of 18 male Sprague-Dawley rats were exposed to air, n-hexane, toluene,
or toluene plus n-hexane, each solvent in a concentration of 1000 ppm; for
21 h/day, 7 days/week for 28 days (111). Neurophysiological recordings were
made 2 days, 3 months, and one year after end of the exposure. Loss of auditory
sensitivity measured by auditory brain stem response was observed 2 days after
exposure in the two toluene-exposed groups. At the two subsequent recordings no
improvement was observed in the group exposed to pure toluene. In the group
exposed to toluene plus hexane a synergistic loss of auditory sensitivity was
observed at 3 months. After one year hearing function had not recovered.
10.4.4 Carcinogenicity
Groups of 120 male and 120 female Fischer F344 rats inhaled toluene 6.5 h per
day, 5 days/week for up to 24 months in concentrations of 0, 112, 375 or
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1125 mg/m3 (0, 30, 100, 300 ppm) (45). No increase in tumour frequency was
seen, however, the exposure level may have been inadequate since the maximum
tolerable dose was not reached.
Groups of 60 male and 60 female F344N rats were exposed by inhalation to
0, 600, or 1200 ppm toluene 6.5 hours/day, 5 days/week for two years in a GLP
study (56). No significant differences in survival were observed between any
groups of either sex. There were no substance-related increases in any tumour
types.
Groups of 60 male and 60 female B6C3F1 mice were exposed by inhalation to
0, 120, 600, or 1200 ppm toluene 6.5 hours/day, 5 days/week for two years in a
study of GLP quality (56). Toluene caused a marginal increase in the occurrence
of non-malignant pituitary tumours (adenomas) in mice. A single adenoma
occurred in each of the three exposed groups of female mice (2%). The
occurrence in the control group was zero, and the historical incidence in chamber
control female B6C3F1 mice was reported as 1/370 (0.3%).
The carcinogenic potential of toluene has been evaluated by IARC. IARC has
evaluated toluene as not classifiable as to its carcinogenicity to humans (IARC
Group 3). The evaluation report describes that toluene has been used as vehicle
control in a number of dermal cancer studies in mice. No clear increase of skin
tumours attributable to toluene was noted (60).
10.5 Mutagenicity and genotoxicity
There are extensive data available on the lack of mutagenicity of toluene to the
standard Salmonella typhimurium test strains (TA1535, TA1537, TA1538, TA98
and TA100) and other Salmonella typhimurium test strains in the plate incorpora-
tion assay (13, 28, 52, 65, 103, 148). Toluene is volatile with a boiling point of
110.6oC, and the standard plate assay is not considered to be able to accommodate
volatile substances without modifications, such as taping of the plates or use of a
dessicator. However, toluene has been found negative in a preincubation test with
the standard Salmonella typhimurium test strains, which may be considered to be
adequate for the test of compounds with boiling points from 107oC to 132oC (57).
Thus, toluene can be considered negative for bacterial mutagenicity in the Ames
Salmonella typhimurium mutation assay.
Toluene has not been found to induce DNA repair mediated toxicity to various
bacteria, gene conversion in the yeast Saccharomyces cerevisiae or genotoxic
effects in Drosophila melanogaster (65, 93, 94, 102, 131, 132, 170).
The genotoxicity of toluene in vitro has been evaluated in several types of
mammalian cells, including cell lines with mouse lymphomas or Syrian hamster
embryo cells, primary rat hepatocytes and human lymphocytes.
Toluene does not appear to induce biologically significant increases in
mutations, sister chromatid exchanges, micronuclei or DNA damage in vitro in
mammalian cells at non-cytotoxic doses (24, 43, 65, 129, 142, 147, 176). Signi-
ficant levels of cytotoxicity have been reached in most studies, and toluene
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therefore appears to have been adequately examined for genotoxic effects in
mammalian cells in vitro.
Toluene has been tested for clastogenicity and other types of DNA interactions
in several in vivo experiments.
Positive results have been obtained in three cytogenetic studies performed in the
former USSR in the 1970s (60). It has, however, been implied that these
significant cytogenetic responses might be due to contamination with benzene.
In more recent studies, toluene has not induced biologically significant increases
in micronuclei and chromosomal aberrations in the bone marrow of mice and rats
or DNA damage in peripheral blood cells, bone marrow, and liver of mice (41, 65,
95, 119, 133). Toluene can be considered to be adequately tested and is con-
sidered non-genotoxic in vivo.
10.6 Reproductive and developmental toxicity
In a 15-week inhalation study (56) no toluene-related effects on sperm morpho-
logy and vaginal cytology in rats exposed to 100, 625, and 1250 ppm toluene
6.5 h/day, 5 days/week were found.
Significantly and dose-related decreased sperm count and reduced epididymal
weight was found in rats exposed via inhalation to a concentration of 2000 ppm
(7500 mg/m3) during 6 h/day for 90 days (113). The NOAEL was 600 ppm
(2250 mg/m3).
Lower foetal weight, lower birth weight and delayed postnatal development
have been reported in a number of studies (30, 51, 53, 55, 114, 156). The
LOAELs are in the range of 1000-2000 ppm (3750-7500 mg/m3), except in two
studies where the LOAELs are below 300 ppm (1125 mg/m3) (30, 55). These two
studies, however, have limitations concerning experimental design and reporting
and the results are not in agreement with the other well-reported and -performed
studies.
The NOAELs are in the range of 400-750 ppm (1500-2812 mg/m3). A NOAEL
for effects on birth weight and postnatal development of 600 ppm (2250 mg/m3)
can reasonably be set.
Increased spontaneous activity and impairments of cognitive functions (learning
and memory) after exposure to toluene during brain development have been found
in two studies (51, 53). Increased spontaneous locomotor activity has been found
after pre- and postnatal toluene exposure to 1200 ppm (4500 mg/m3) (51).
Prenatal exposure alone caused no significant effects on locomotor activity (24 h)
(156). Investigations of short-term activity after prenatal exposure to 1800 (53) or
2000 ppm (114) (6750 mg/m3 or 7500 mg/m3) toluene have not shown significant
effects on activity. Impairment of cognitive function measured in the Morris water
maze has been found in one study where rats (especially females) prenatally
exposed to 1800 ppm toluene (6750 mg/m3) were examined as young adults (53).
In another study pre- and postnatal exposure to 1200 ppm of toluene
(4500 mg/m3) also caused deficits in exposed females in a similar cognitive task
(51).
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Thus, the LOAEL for the behavioural effects is 1200 ppm (4500 mg/m3) and a
NOAEL cannot be established since lower exposure levels were not investigated.
Courtney et al. (29) found some signs of foetotoxicity of toluene in mice at
400 ppm (1500 mg/m3). There was no level without effect in this study. Jones &
Balster (70) found lower birth weight, decreased postnatal weight gain, and
delayed reflex development in the absence of maternal toxicity at 2000 ppm
toluene (7500 mg/m3). The NOAEL was 400 ppm (1500 mg/m3), but the daily
exposure periods were limited to 3 hours.
Effects on behaviour in the absence of maternal or general toxicity have been
reported in mice after perinatal dosing with approximately 60 mg/kg/day toluene
(79). The administration route was via drinking water.
In rabbits equivocal effects were found in a study comprising two teratology
tests (75). In the first part of the study (n=14) slight delays in skeletal develop-
ment were registered at 500 ppm (1875 mg/m3). No effect was observed in the
second part of the study at the same exposure level (n=20).
11. Observations in man
11.1 Effects by contact and systemic distribution
11.1.1 Skin
Toluene has a degreasing effect on the skin. After repeated exposures, irritative
contact dermatitis may develop (15, 42).
11.1.2 Eye
Eye irritation in toluene-exposed human volunteers has been examined in two
studies (4, 33). In one of the studies (4), 16 volunteers were exposed for 6 hours to
0, 10, 40 or 100 ppm on each of 4 test days in random sequence. No change in
lung function or nasal mucus flow was found. At 100 ppm irritation in the eyes
and the nose was experienced. There was a significant deterioration in the per-
ceived air quality and a significant increased odour level at all toluene concen-
trations. At 150 mg/m3 (40 ppm) no irritation was registered. In the other study
comprising 42 subjects (33), twice as many complaints of eye irritation were
registered at 150 ppm as at 0 ppm. The two studies show that complaints of eye
irritation start at air concentrations around 100 ppm (375 mg/m3).
11.2. Effects of repeated exposure on organ systems
11.2.1 Liver
In 47 toluene-exposed workers a significant increase in S-ALP (serum alkaline
phosphatase) compared with a referent group of 46 non-exposed workers was
found (153). The association was still significant when heavy alcohol consumers
were excluded from the analysis. The exposure levels measured by personal
sampling were generally below 80 ppm. Other liver function-related enzyme
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levels were unaffected. There was no association with cumulative exposure.
Because of possible confounding by alcohol and lack of supportive evidence of
liver toxicity from animal studies, the findings in this study are considered of
doubtful relevance.
11.2.2 Kidneys
Sniffing of toluene results in reversible kidney damage evidenced as renal tubular
acidosis (158). In some cases sniffing resulted in irreversible kidney damage
(tubular dysfunction and interstitial nephritis) (134).
A workplace accident with massive toluene exposure for 18 hours resulted in
renal failure with oligouria probably caused by dehydration and myoglobinuria
(128).
Inhalation of 382 mg/m3 (100 ppm) toluene for 6.5 hours in an exposure
chamber resulted in unchanged excretion of albumin and beta-2-microglobulin in
43 printers with occupational exposure to toluene as compared to 43 age-matched
controls without occupational exposure to toluene (107).
No signs of renal damage in 118 painters were found compared with a control
group. The painters had an average of 9 years occupational exposure to toluene
and xylenes. At the time of investigation the exposure was approximately
94 mg/m3 (25 ppm) as determined from metabolites in urine (38).
In 42 printers with an occupational toluene exposure averaging 300 mg/m3
(range 100-900 mg/m3) compared with 48 unexposed controls, no changes in
glomerular filtration rate, renal concentrating ability, beta-2-microglobulin
excretion, and excretion of erythrocytes and leukocytes were found (6).
11.2.3 Blood
Among 24 solvent abusers (21 males, 3 females), 8 long-term users had
lymphocyte abnormalities (5 lymphopenia, 3 lymphocytosis). Three subjects
(2 were women) had a normocytic-normochromic anaemia (36).
In a study including 38 female workers employed with shoe gluing and a
control group of 16 women from the same plant, but not exposed to organic
solvents, the values of blood density, haemoglobin content, haematocrit and
number of leukocytes were not different. The toluene concentration was
60-100 ppm measured during a year. However, the Mommsen toxic granula in the
peripheral neutrophils developed faster in the group exposed to toluene. Since
other blood parameters were not affected, the latter finding is not considered
adverse. Furthermore, the exposure may not have been purely to toluene, as it is
stated in the publication that gasoline (20-50 ppm) was detected in some samples
(92).
11.2.4 Cardiovascular system
In a study involving 325 printers, past toluene exposure was elucidated through a
questionnaire and an interview. The mean exposure level was approximately
375 mg/m3 (100 ppm) for twenty years preceding the investigation. The informa-
tion was used to group the printers according to an exposure index. A slight
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increase in systolic blood pressure showed correlation with increasing toluene
exposure, as judged by the exposure index. For 133 of the printers systolic blood
pressure was measured before and after an exposure-free period of six weeks. The
exposure-free period resulted in a significant decrease in systolic blood pressure.
No significant changes were observed in diastolic blood pressure (101).
11.2.5 Central nervous system
The results achieved by 16 volunteers in a number of performance tests were not
influenced by 6-h inhalation of toluene in concentrations up to 375 mg/m3 (100
ppm). At 375 mg/m3 (100 ppm) headache, dizziness, and feeling of intoxication
were more often reported by the study subjects than at the lower concentrations (0
mg/m3, 37.5 mg/m3 (10 ppm), 150 mg/m3 (40 ppm)) (4).
A one-hour inhalation of toluene (472-588 mg/m3 (126-157 ppm)) was found to
affect nystagmus reflexes (visual suppression) in 15 volunteers (58).
For 12 volunteers inhaling 300 mg/m3 (80 ppm) toluene for 4.5 hours, the
results in 4 performance tests carried out after 2 and 3.5 hours of exposure were
not significantly different from the results obtained from the same persons during
exposure to clean air. Subjective complaints of headache and irritation were more
frequent at toluene exposure, during which a small decrease in the pulse at rest
was observed (64).
Among 8 male post-graduate students exposed to 80 ppm toluene for 4 hours
no difference in results in four choice reaction time, four choice errors, simple
reaction time, visual search, visual analogues and stressalyser could be found
compared to the results obtained by the same subjects exposed to clean air for
4 hours (26).
For 20 volunteers inhaling 98 ppm toluene for 4 hours the results in the psycho-
motor tests finger tapping, reaction time, pursuit-rotor test and Purdue hand
precision test did not differ from control values obtained by the same 20 volun-
teers (169).
Following chamber exposure to 375 mg/m3 (100 ppm) toluene for 6.5 hours, 43
printers with 9 to 25 years of occupational toluene exposure did not show signi-
ficantly different results in 10 performance tests compared with an equally sized
group not previously exposed to toluene and matched for sex, age, education and
smoking habits. Toluene chamber exposure was found to decrease manual
dexterity, colour discrimination, and accuracy in visual perception in both groups
(17).
Forty-two college students inhaled 0, 281 mg/m3 (75 ppm) or 562 mg/m3
(150 ppm) toluene for seven hours on each of three days. The students carried out
a number of performance tests prior to exposure, and after three and seven hours
of exposure. On each day students served as their own control. Toluene exposure
resulted in significantly poorer results in digit span, pattern memory, pattern
recognition, symbol digit, and one hole test. The number of symptoms recorded
was found to increase with increasing toluene exposure for headache and mucosal
irritation. A dose response relationship was found in the number of times subjects
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slept increasing from 7% at 0 ppm, 14% at 281 mg/m3 (75 ppm), to 22% at 562
mg/m3 (150 ppm) (33).
A random population sample of 32 male and 39 female subjects were allocated
into three groups, one exposed to clean air, one exposed to a constant toluene
level (100 ppm), and one exposed to varying concentrations of toluene (fourteen
30-minute episodes/day, each episode starting with an increasing concentration
reaching a peak of 300 ppm after 5 min and then decreasing to a stable period of
about 15 min at 50 ppm, giving a time weighted average (TWA) of 100 ppm for
the whole exposure period). Toluene caused throat and respiratory irritation,
headache and dizziness. In performance tests only minimal effects were found.
There was no difference between constant exposure and peak exposure (18).
Humans exposed to high levels of toluene as a result of toluene abuse or
industrial accidents may experience serious nervous system effects including fatal
CNS depression. Other effects include cerebellar, pyramidal and cognitive dys-
function such as tremor, ataxia and memory impairment (158).
In a study of hospitalised solvent abusers, 24 patients with a mean age of 23    +
4.4 years and 6.3    + 3.9 years of toluene sniffing were examined. Present toluene
consumption was 160-425 mg toluene/day (36). Computed tomography (CT)
scanning results from 14 subjects revealed significant brain atrophy when the
study subjects were compared with 20 age-matched controls, who were
investigated for other non-solvent related neurological disorders.
A study of four toluene-sniffing patients (85) showed, in addition to neuro-
logical symptoms and findings, severely affected brain stem auditory evoked
potential in three of the four patients tested. Audiometry showed mild abnormality
in one of three patients. Moderate to severe oculomotor abnormality was found in
three out of the four, and moderate to severe atrophy of the cerebellum in two of
the patients.
Several cross-sectional studies have been found, in which a toluene-exposed
group of workers have been compared with a matched control group. The studies
in which the exposure was predominantly to toluene, and where an estimate of
exposure levels was made, are shown in Table 2. The studies have revealed
increased prevalence of subjective complaints (fatigue, recent memory failure,
concentration difficulty, mood lability, depressive feelings, irritability, headache,
dizziness, sleep disturbances, paresthesia, chest oppression, sexual problems) (86,
177), neuropsychological impairments (10, 35, 39, 63), electrophysiological
changes (1, 165), and increased prevalence of neurasthenic complaints, short-term
memory complaints, and organic brain syndrome (177).
11.2.6 Auditory system
The hearing ability of 50 workers exposed to noise (88-98 dB (A), 51 workers
exposed to noise and toluene (100-300 ppm), and 39 workers exposed to a
mixture of solvents (toluene, xylene, methyl ethyl ketone) was compared with an
unexposed control group of 50 workers by pure tone audiometry and immittance
audiometry. The groups were comparable with respect to age, previous exposure
to noise and chemicals, medical history (diabetes, hypertension, ear infections,
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and ototoxic medication), and noise related life-style factors (hunting, shooting,
motor sports, amplified music, power tools, and military service (96).
High-frequency bilateral hearing loss was found in 8% of the unexposed, 26%
of the noise-exposed, 53% of the noise- and toluene-exposed, and 7% of the
solvent-exposed. The group exposed to noise plus toluene had significantly more
workers with mild high frequency hearing loss (30-40 dB) than did all the other
groups (p<0.001). The acoustic reflex measurements showed that the reflex decay
in the toluene plus noise group was significantly higher than in the other groups
(p<0.001). A multiple logistic regression for occupational hearing loss carried out
on the four groups revealed that the relative risk was highest in the toluene plus
noise group (10.9), followed by the solvent group (5.0), and the noise group (4.1).
The study strongly indicates that occupational exposure to toluene increases the
risk of developing occupational noise-related high-frequency hearing loss (96).
A group of 124 printing workers, all of whom were exposed to various levels of
noise and a mixture of toluene, ethyl acetate, and ethanol underwent pure-tone
audiometry and immittance audiometry testing after having been interviewed
according to a comprehensive questionnaire (97). A personal average exposure
evaluation, based on air samples from the breathing zone of each subject, was
conducted for all the subjects for toluene, ethanol, and ethyl acetate. The total
toluene exposure was assessed by monitoring of hippuric acid in urine samples
collected immediately after each workday. Ethanol levels ranged from 0.25 to
1240 mg/m3, ethyl acetate from 1.1 to 2635 mg/m3, and toluene from 0.14 to
919 mg/m3. Noise levels, measured via personal noise dosimeters, were in the
range of 71 to 93 dB (A).
Forty-nine percent of the workers had hearing loss. Numerous variables were
analysed for their contribution to the development of hearing loss. Only age and
hippuric acid in urine were significantly associated with hearing loss. The odds
ratio for hearing loss relative to hippuric acid was calculated. However, hippuric
acid is problematic as a marker of toluene exposure, because of the variability in
the natural background level of this substance. Therefore the odds ratio calcu-
lations may be based on incorrect assumptions, but the study does still provide an
indication that occupational exposure to toluene increased the probability of
hearing loss in the study population.
11.3 Genotoxic effects
Equivocal results were obtained in a multitude of studies with biological
monitoring of various genotoxic effects in peripheral blood lymphocytes from
workers exposed to toluene in the occupational environment (Table 3).
Confounding due to coexposure to ink, other solvents and various genotoxic
substances in the environment cannot be excluded. Furthermore, a clear
synergistic effect between toluene exposure and smoking was demonstrated (50).
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Table 3. Studies of genotoxic effects of toluene in workers
Exposure level Groups studied Effects in peripheral blood
lymphocytes
Re
f.
Average 200 ppm for
3-15 years
24 rotogravure workers,
age 29-60 years, 24 controls
No increase in CA (37)
100-200 ppm with occa-
sional rises to 500-700
ppm for 1.5-26 years
14 rotogravure workers,
age 23-54 years; 49 controls
Significant increase in CA (40)
7-112 ppm for 3-35 years 32 rotogravure workers,
age 21-50 years; 15 controls
No increase in CA or SCE (100)
mixed solvent exposure,
toluene 1-157 mg/m3
(0-50 ppm)
17 paint industry workers,
17 controls
No increase in SCE, or in CA
of 5 most heavily exposed
workers
(49)
200-300 ppm toluene
for >16 years
20 rotogravure workers, age
32-60 years, 24 controls
Significant increases in CA and
SCE
(7)
104-1170 ppm
(390-4388 mg/m3)
for 12 years
42 rotogravure workers,
mean age 39 years, 28
office and technical
employees, 32 controls
Significant increase in CA, not
controlled for smoking or co-
exposure to ink mist
(116)
40 ppm (150 mg/m3) 21 rotogravure printers,
21 controls
Significant increases of MN, no
increase in CA, not controlled
for age and smoking
(109)
19 ppm (70 mg/m3)
for 18 years
20 shoe workers, age 29-56
years, 20 controls
Significant increase in SCE and
DNA damage, no dose
correlation
(121)
65 filling station attendants,
no control group
No increase in urinary 8-OHdG (81)
benzene and toluene 38 and 45 shoe workers,
control workers
Significant increase in SCE,
possibly related to benzene
exposure
(72)
benzene (up to 15 ppm)
and toluene (up to 50
ppm)
49 shoe workers, mean age
38 years, 27 controls
Significant increase in dicentric
chromosomes
(50)
38-88 ppm (141-328
mg/m3) for 18.9 years
42 rotogravure workers, age
22-60 years, 45 controls
Significant increases in SCE,
not controlled for co-exposure
to ink mist
(50)
26-110 ppm
(96-412 mg/m3) for an
average of 12 years
34 shoe workers, mean age
38 years, 19 controls
No difference in Comet assay (118)
CA=structural chromosomal aberrations. SCE=sister chromatid exchanges. MN=micronuclei.
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11.4 Carcinogenic effects
In the IARC evaluation of toluene (60), four case-control studies involving several
anatomical sites of cancer are mentioned. The results could not be evaluated with
regard to toluene itself, because the exposure was to mixtures of solvents and not
to pure toluene.
A cohort of 1020 rotogravure printers exposed to toluene and employed for a
minimum period of three months in eight plants during 1925-85 was studied
(152). Based on the measurements in the 1940s and 1950s the maximum toluene
concentration was about 450 ppm, but it was only about 30 ppm in the mid 1980s.
Exposure to benzene had occurred up to the beginning of the 1960s. Compared
with the regional rates, total mortality did not increase during the observation
period 1952-86. There was no increase in mortality from non-malignant diseases
of the lungs, nervous system, or gastrointestinal and urinary tracts. There was no
overall excess of tumours in the years 1958-85. Among the specific cancers only
those of the respiratory tract were significantly increased. However, statistical
significance was not attained, when only subjects with an exposure period of at
least five years and a latency period of at least 10 years were considered.
The mortality from various cancer forms in a cohort of 6830 male and 751
female workers in the German rotogravure industry has been investigated (167).
A significantly higher mortality due to bone and connective tissue tumours was
identified, based on a low number of cases. Also mortality due to lung tumours,
brain tumours, and tumours of the nervous system was increased, but not to a
level reaching statistical significance. Although it is not clear from the report, the
basis for cancer diagnoses seems to be death certificates, which probably is not an
accurate source for this information.
11.5 Reproductive and developmental effects
11.5.1 Effects on hormones
Twenty men from a rotogravure printing company with a mean duration of
employment of 25 years (range 0.5-37) and a mean age of 48.2 years (range
30-63) were compared with 44 male industrial workers without exposure to
organic solvents and a mean age of 39.0 years (range 23-63) for concentrations of
ten hormones in serum (151). With respect to the printers, the individual time
weighted average toluene concentration in air was 36 ppm (range 8-111), the
toluene level in blood was 1.7 µmol/l (range 1.0-6.6) and in adipose tissue
5.7 mg/kg (range 2.5-21). There was a negative association between blood toluene
and plasma levels of prolactin. The exposed group had significantly decreased
concentrations of follicle stimulating hormone (FSH), luteinising hormone (LH),
and free testosterone; and an increase in the concentration of triiodothyronine
compared with the control group. No correlation was found between cumulative
exposure and plasma hormone concentrations. In eight printers, the levels of FSH
and LH increased during a 4-week vacation, indicating reversibility; while levels
of thyroid stimulating hormone, free triiodothyronine, and free thyroxin de-
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creased. The observed effects were rather small with most hormone levels being
within the reference limits.
Forty-seven men from two rotogravure printing companies were studied for
their hormone status (153). In company A, the 28 men had a mean duration of
employment of 18.4 years (range 4-33 years). In company B, the 19 men had a
mean duration of employment of 14.5 years (range 3-39 years). Twenty-three
workers from a metal industry and 23 craftsmen from hospital workshops were
used as referents. The mean age for the exposed group was 44.4 years (range 23-
62 years), and for the referents it was 43.5 years (range 20-61 years). Occupa-
tional exposure to toluene was measured for each working shift over a week, and
the workers were divided into exposure groups based on these data. In company
A, the following exposure groups were found: <5 ppm, 5-10 ppm, 10-15 ppm, and
in company B the following: 20-25 ppm, 35-45 ppm, and >45 ppm. The referents
had no exposure to toluene or other solvents. No statistically significant differ-
ences were found in any of the hormone concentrations between the total exposed
and referent groups, however, younger members of the exposed group had signi-
ficantly lower plasma LH, FSH, and testosterone levels. Increasing exposures to
toluene (at the present exposure level) were significantly associated with de-
creasing plasma concentrations of LH and testosterone. No correlation was found
between cumulative exposure and plasma hormone concentrations.
The authors conclude that the results of the two above-mentioned studies
indicate that low-level toluene exposure (below the Swedish occupational
exposure limit; at the time of sampling 80 ppm) may affect the hypothalamus-
pituitary axis. Possible explanations include a link to toluene-induced changes in
neurotransmitter levels, or to dopamine-like activity of toluene or its metabolites.
Also, the possibility of reduced pituitary function in connection with a general
depression of brain functions in relation to organic brain syndrome (which was
not diagnosed in any of the exposed workers) was mentioned by the authors (151,
153).
The effects identified in these studies cannot be regarded as directly adverse,
since the hormone levels were within reference limits, and the effects seemed to
be reversible. The studies do, however, give evidence of a possible interference
with endocrine mechanisms by toluene.
11.5.2 Fertility
In a cross sectional study, a sample of 150 male and 90 female printing industry
workers in Germany were interviewed retrospectively on reproductive exper-
iences (120). There was no association between occupational exposure to toluene
and subfecundity in men and their partners. In women who worked in exposed
areas, a significant reduction of fecundability of about 50% was found compared
with periods working in other industries. The women worked exclusively in the
stacking and bookbinding process, where the overall exposure to toluene was
classified as low (<10 ppm). As toluene has been exclusively used in the German
printing industry since 1960, exposure to other chemicals can be excluded.
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The finding of the study indicate that an adverse effect of toluene on male
fecundity is unlikely but cannot be completely excluded. For women, after
considering possible biases, low daily exposure to toluene seems to be associated
with reduced fecundity. Other forms of exposure such as noise and stress were not
examined in the study and cannot therefore be excluded as having produced part
of the findings or the overall result in the women. Also, there is a potential for
recall bias in this study, e.g. persons with undesirable outcome may have recall of
exposure that are different from those who do not experience the outcome. This
applies for men as well as women and it is therefore considered impossible to
draw clear conclusions from this study.
Rates of menstrual disorders were studied in 231 female production workers
exposed to toluene (mean 88, range 50-150 ppm) and compared with a control
group of 58 production workers in other departments of the same factory where
little or no exposure to toluene ocurred (0-25 ppm) (104). An external community
control group of 187 working class women was also studied. There was no evi-
dence that menstrual disorders were likely to result from exposure to toluene.
11.5.3 Developmental toxicity
Several case reports of mothers giving birth to children with so-called toluene
embryopathy as a result of toluene sniffing during pregnancy have appeared.
Microcephaly, narrow bifrontal diameter, short palpebral fissures, deep-set eyes,
small midface, low-set, prominent ears, micrognathia, spatulate fingertips, small
fingernails, hypotonia, and hyperreflexia were found in the children. In total about
45 cases have been described in the literature (115). These cases all very much
resemble the foetal alcohol syndrome, and there might be a common mechanism.
Spontaneous abortions among women working in laboratories, and congenital
malformations and birth weights of the children were examined in a retrospective
case-referent study (155). The exposure to toluene was assessed on the basis of
the reported frequency of the use of the chemical and classified as frequent if the
chemical was handled at least 3 days a week and rare if the toluene was handled 1
or 2 days a week. Significant associations with spontaneous abortions were found
for frequent exposure to toluene (odds ratio 4.7, confidence interval 1.4 to 15.9)
after adjustment for various covariates (206 cases and 329 referents). No associ-
ation with congenital malformation was found (36 cases and 105 referents),
however, the number of persons in the malformation study was too small for
drawing final conclusions.
Rates of spontaneous abortions were determined using a reproductive question-
naire in 55 women with 105 pregnancies exposed to toluene (mean 88 ppm, range
50-150 ppm) and 31 women (68 pregnancies) working in the same factory in
departments where little or no exposure to toluene occurred (0-25 ppm) (105). An
external community control group of 190 working class women with 444 preg-
nancies was also studied. Significantly higher rates of spontaneous abortions were
noted in the toluene exposed women compared with those in the internal and
external control groups (12.9% vs. 2.9-4.5%). The rate differences between
groups were not likely to be confounded by classical risk factors such as maternal
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age, gravidity, smoking, or alcohol, which were taken into account both in the
study design and the analysis.
12. Dose-effect and dose-response relationships
The key studies for evaluation of the important effects of toluene are listed in
Table 4 and Table 5. The animal studies presented in Table 4 have been selected
because they are considered to be reliable in that a sufficient number of study
subjects have been included, the endpoints are relevant for hazard identification,
and appropriate test methods have been used. A number of other studies,
including studies investigating the nervous system, examine endpoints which are
less well established as predictive of human adverse health effects. Such studies
have not been included in Table 4. With respect to auditory and reproductive
toxicity, only one study reference is presented in the table for each of these
endpoints. However, a large number of other studies have examined these
endpoints and yielded similar results, and thus bring support to the selected key
studies. General toxicity has been investigated in two 2-year studies. Although
other studies with shorter duration have also been performed, it is believed that
the studies of the longer duration are the most relevant for prediction of human
long-term hazard.
Table 4. LOAELs and NOAELs from animal studies
Exposure level Exposure
duration
Species Effects Reference
30 000 mg/ m3
8000 ppm
4-6.5 h Rat lethal (LD50) 11, 19, 122, 146
3750 mg/m3
1000 ppm
2 weeks Rat LOAEL for auditory toxicity 125
3750 mg/m3
1000 ppm
gestation day
9-21
Rat LOAEL for reduced birth
weight and retarded postnatal
development
156
2625 mg/m3
700 ppm
16 weeks Rat NOAEL for auditory toxicity 125
2250 mg/m3
600 ppm
2 years Rat LOAEL for nasal toxicity and
general toxicity (nasal toxicity
and stomach ulcers)
56
2250 mg/m3
600 ppm
gestation day
9-21
Rat NOAEL for reduced birth
weight and retarded postnatal
development
156
1125 mg/m3
300 ppm
2 years Rat NOAEL for general toxicity 45
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Table 5 includes the human studies, which are considered the most relevant for
description of the important health effects identified in man. Additional studies
exist which examine other endpoints for which the toxicological significance is
less certain; these studies have not been included in the table.
Liquid toluene is irritating to skin and eyes in animals, while toluene vapours in
concentrations at and above 100 ppm causes complaints of eye irritation in
humans.
In the rat, a NOAEL for general systemic toxicity of 300 ppm for repeated
exposure via inhalation was identified in a 2-year study. In another 2-year study
higher exposure levels (600 ppm) resulted in nasal toxicity and increased inci-
dence of stomach ulcers. For the dermal route, no systemic toxicity data have been
found.
Toluene has been shown to affect the central nervous system and the inner ear.
In humans exposed under experimental conditions headache, dizziness, feeling
of intoxication, irritation and sleepiness were recorded to occur with significantly
increased frequency at exposure levels from 562 mg/m3 (150 ppm) down to
375 mg/m3 (100 ppm). At 150 mg/m3 (40 ppm) and below the effects have not
been recorded to occur with increased frequency. For these subjective symptoms a
lowest observed adverse effect level (LOAEL) of 375 mg/m3 (100 ppm) and a no
observed adverse effect level (NOAEL) of 150 mg/m3 (40 ppm) can be
established.
Experimental chamber inhalation of 375 mg/m3 (100 ppm) toluene for 6.5
hours, or inhalation of 281 mg/m3 (75 ppm) and 562 mg/m3 (150 ppm) by
volunteers for 7 hours have resulted in significantly poorer results in a number of
performance tests, indicating a LOAEL of 281 mg/m3 (75 ppm) for these tests. A
NOAEL of 150 mg/m3 (40 ppm) for performance tests can be deducted from the
study of Andersen et al.(4).
13. Previous evaluations by (inter)national bodies
The IPCS International Programme on Chemical Safety concluded that exposure
of the general public and environment does not present any health and/or environ-
mental hazard. However, the report further concluded that solvent abuse and long-
term occupational exposure to toluene may be associated with permanent patho-
logical changes, but did not mention which changes or at what exposure levels
(62).
The Nordic Expert Group for Documentation of Occupational Exposure Limits
concluded in 1989 that occupational exposure limits (OELs) for toluene should be
based on acute effects on the nervous system, and that the fact that toluene rarely
occurs alone, and that it possibly has an effect on reproduction and on the defence
mechanism towards infection of mucous membranes should also be considered
(66).
The IARC evaluation 1989 stated that there is inadequate evidence for the
carcinogenicity of toluene in humans and in experimental animals. The overall
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evaluation was that toluene is not classifiable as to its carcinogenicity to humans
(Group 3) (60).
In a draft updating a previous evaluation on toluene by the U.S. Department of
Health & Human Services the acute-duration and chronic-duration inhalation
MRLs (Minimal risk levels) were based on CNS effects in humans. The draft is
publicly available (158).
The Danish EPA has evaluated toluene (latest draft version May 2000) within
the EU existing substances risk assessment programme. The conclusions of this
draft are not yet available (May, 2000) but a copy of the draft can be obtained
from the Danish EPA.
14. Evaluation of human health risks
14.1 Groups at extra risk
Exposure to noise may enhance the hearing loss induced by toluene. This has been
shown to occur in the rat, and there are indications that man is also susceptible.
Rat studies show that noise and toluene interact also when exposure is not simul-
taneous. Workers exposed to toluene in a noisy working environment, or who are
exposed to noise at other occasions, are therefore considered to be at increased
risk for developing hearing loss.
Toluene exposure is associated with an increased risk for spontaneous abor-
tions. Women in fertile age are therefore a group at extra risk.
14.2 Assessment of health risks
A large database exists for the toxic effects of toluene in animals and man. End-
points of concern include eye irritation, reproductive toxicity, ototoxicity, and
neurotoxicity. The dose-response relation for eye irritation has been determined in
experimental human exposure studies of good quality. There are several inde-
pendent studies indicating increased risk of spontaneous abortion in women, and
this is supported by evidence from animal studies. Ototoxicity of toluene is well
documented in animals and two epidemiological studies indicate similar effects in
man. The dose-response relation for acute neurotoxicity has been determined in
experimental human exposure studies of good quality. Several epidemiological
studies show a relation between long-term exposure and organic toxic encephalo-
pathy, however, the dose-response is not well described.
14.3 Scientific basis for an occupational exposure limit
The major concerns for human health are reproductive toxicity, ototoxicity, and
neurotoxicity. The LOAELs and NOAELs, if known, are shown in Table 5. The
following may be considered for setting occupational exposure limits: Increased
risk for spontaneous abortion has been identified in a group of women exposed to
32
50-150 ppm (average 88 ppm) toluene. For eye irritation, headache, and feeling of
intoxication the LOAEL is 100 ppm and the NOAEL is 40 ppm. The LOAEL for
deterioration in the perceived air quality and increased odour level is 10 ppm.
15. Research needs
There is a need for further investigation of the ototoxic effects of toluene in
humans to allow determination of the time, dose-response relationship.
The study of mechanisms for the various toxicity endpoints is important. Also,
the dose-response relationship for reproductive toxicity needs to be explored. CNS
damage in laboratory animals should also be further investigated.
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16. Summary
Østergaard Grete. Toluene. Arbete och Hälsa 2000;19:1-51.
The major route of toluene exposure is inhalation. Toluene is to a large extent
metabolised in the liver and excreted in urine as hippuric acid.
Toluene has a low acute toxicity. Toluene vapours causes complaints of eye
irritation, headache and dizziness. Toluene sniffing causes severe neurological
abnormalities and brain atrophy, while it is possible that organic brain syndrome
may develop in workers exposed to toluene for many years. Toluene may cause
hearing loss in workers and the effect is enhanced if noise is present. Toluene
abuse in pregnant women is associated with physical and neurological abnormali-
ties in their foetuses. Lower birth weight and impairment of learning ability have
been demonstrated in rats exposed in utero. An increased rate of spontaneous
abortions in toluene-exposed female workers has been found.
The major concerns for human health are reproductive toxicity, ototoxicity, and
neurotoxicity.
The rate of spontaneous abortion has been shown to be increased in women
exposed to 50-150 ppm toluene (average 88 ppm). For eye irritation, headache,
and feeling of intoxication the LOAEL is 100 ppm and the NOAEL is 40 ppm.
The LOAEL for deterioration in the perceived air quality and increased odour
level is 10 ppm.
Keywords: chronic toxic encephalopathy, irritation, neurotoxicity, occupational
exposure limits, ototoxicity, toxicity, reproductive toxicity, toluene
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17. Summary in Danish
Østergaard Grete. Toluene. Arbete och Hälsa 2000;19:1-51.
Toluene optages hovedsageligt ved indånding og udskilles hovedsageligt efter
omsættelse i leveren som hippursyre i urinen.
Toluen har lav akut giftighed. Toluendampe giver anledning til øjenirritation,
hovedpine og svimmelhed. Toluen-sniffing forårsager alvorlige neurologiske
forstyrrelser og svind af hjernevæv, mens det er muligt, at organisk hjerneskade
kan udvikles hos arbejdere efter mange års udsættelse. Toluen kan forårsage
nedsat hørelse, og effekten forværres, hvis man også udsættes for støj. Toluen-
misbrug hos gravide kvinder fører til fysiske og neurologiske skader hos børnene.
Når rotter udsættes for toluen i fostertilstanden, finder man lavere fødselsvægt og
nedsat indlæringsevne. Hos toluenudsatte kvindelige arbejdere er det påvist, at
antallet af spontane aborter er forøget.
De største bekymringer for menneskets sundhet er reproduktionsskader, skader
på hørelsen og skader på nervesystemet.
Forøget forekomst af spontan abort er påvist hos kvinder, der blev udsat for
koncentrationer mellem 50 og 150 ppm (middelværdi 88 ppm).
For øjenirritation, hovedpine og følelse af giftpåvirkning er LOAEL 100 ppm
og NOAEL 40 ppm. LOAEL for subjektiv oplevelse af nedsat luftkvalitet og øget
lugt er 10 ppm.
Nøgleord: hygiejnisk grænseværdi, irritation, kronisk toksisk hjerneskade,
malersyndrom, neurotoksicitet, ototoksicitet, reproduktionstoksicitet, toluen,
toksicitet
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In the search for literature the following data bases were used:
-Medline
-Toxline
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Appendix 1.
Occupational exposure limits for toluene in air.
Country ppm mg/m3 Comments Year Ref
Denmark 25 94 Skin uptake 1996 1
Finland 50 190 Skin uptake 1998 2
100 380 15 min short term 1998 2
Germany 50 190 Skin uptake 2000 3
Iceland 25 94 Skin uptake 1999 4
Netherlands 40 150 2000 5
Norway 25 94 Skin uptake 1996 6
Sweden 50 200 Skin uptake 2000 7
100 400 15 min short term 2000 7
USA (ACGIH) 50 Skin uptake 2000 8
(NIOSH) 100 375 2000 9
150 560 15 min short term 2000 9
(OSHA) 200 2000 9
300 Ceiling value 2000 9
500 10 min short term 2000 9
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